Stock screener

AGEN

Conviction 20HealthcareScan · Thu, Jun 25, 2026
AGEN$2.89-1.03%
ResistanceSupportVol 14
63 bars
Vol MA14 727.32K
Mar 26Apr 14May 1May 19Jun 8Jun 25
AGENUS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.agenusbio.com
Price2.89
Change-1.03%
Gap+1.54%
Rel volume3.24×
Avg volume686.5K
Avg $ vol2.17M
SMA 203.19
SMA 503.54
SMA 2003.70
Price vs 50-18.30%
Price vs 200-21.96%
MA stackbearish
50/200 cross
Supertrenddown · 3.59
RSI (14)38
MACD hist-0.01
MACD crossbear · 5d
Stoch %K / %D7 / 17
ADX (14)13
+DI / −DI16 / 24
RSI divergence
MACD divergence
ATR %+7.82%
ADR %6.52%
52w high7.06
52w low2.77
From 52w high-59.07%
Above 52w low+4.33%
New 52w highNo
SqueezeOff
Bollinger width23.76%
%B0.11
Donchian pos5.88%
Donchian high3.53
Donchian low2.85
AVWAP (52w high)4.15
vs AVWAP high-30.29%
AVWAP (52w low)3.63
vs AVWAP low-20.42%
OBV trendDown
Chaikin MF (20)-0.23
Today vs 20d3.24×
Avg vol (14d)727.32K
Avg vol (20d)686.5K
Avg $ vol (20d)2.17M
Market cap120.35M
RS 3m (vs SPY)-30.23%
RS 6m (vs SPY)-22.85%
RS line new highNo
Trend template0/8
Technical rank16.2
1 week-2.36%
1 month-12.95%
3 months-18.82%
6 months-17.66%
1 year-42.20%
YTD-10.53%
P/E-1.00
P/B-0.54
P/S1.05
P/FCF-1.56
EPS0.0000
Div yield
ROE54.56%
ROA-64.73%
Debt/Eq-0.14
Current0.38
EV/EBITDA-11.36
Gross margin
Net margin-105.69%
Rev growth10.37%
EPS growth4.96%
Price target
Target upside
Analyst rating
Institutional
Ent. value115.54M
Revenue33.74M
Net income-33.73M
Gross profit
Free cash flow-77.2M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out41.64M
Employees81
ListedFri, Feb 4, 2000
Free float35.54M
Float %92.6%
Short interest5.46M
Days to cover8.3d
Short volume66.2%
Squeeze score88 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction20 / 100
Pattern quality
Tech rank16.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance3.95
Support2.94
Days since event
Candle confirm
News sentiment

Financials as of Sun, Sep 30, 2018 · quarterly.

Congress activity

Disclosed STOCK Act trades in AGEN

All disclosures →
No recent disclosed trades by Congress in AGEN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AGEN · 7 buys

InsiderSideShares
ARMEN GARO H
See Remarks · Common Stock · 2026-06-12
Grant4.92K
ARMEN GARO H
See Remarks · Common Stock · 2026-05-29
Grant4.64K
ARMEN GARO H
See Remarks · Common Stock · 2026-05-29
Other
ARMEN GARO H
See Remarks · Common Stock · 2026-05-15
Grant4.54K
ARMEN GARO H
See Remarks · Common Stock · 2026-05-15
Other
ARMEN GARO H
See Remarks · Common Stock · 2026-05-01
Grant4.23K
ARMEN GARO H
See Remarks · Common Stock · 2026-05-01
Other
Wright Timothy
Director · Stock Option · 2026-04-24
Grant105K
Buell Jennifer
See Remarks · Stock Option · 2026-04-24
Grant300K
O'Day Steven J
Chief Medical Officer · Stock Option · 2026-04-24
Grant70K

SEC filings

EDGAR filings in AGEN · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.